Provivi has raised $152.0M in total across 3 funding rounds.
Provivi's investors include Kairos Ventures.
# High-Level Overview
Provivi is a science-based agricultural technology company developing pheromone-based crop protection solutions as safer alternatives to conventional pesticides.[1][2] Founded in 2013, the company creates mating disruption products that use naturally occurring insect pheromones to control pest populations while preserving beneficial insects and reducing chemical residue in crops.[1][3] Provivi serves farmers globally, particularly those growing high-acreage staple crops like corn, rice, and soy, addressing the dual challenge of effective pest management and sustainable agriculture.[2][3]
The company's growth momentum is accelerating through strategic partnerships with major agricultural players. Provivi has commercialized its flagship Nelvium™ product with Syngenta for rice pest control in Indonesia and is expanding collaborations with companies like Godrej Agrovet in India.[3][4] As of recent reports, Provivi holds 21 government registrations across seven countries and five continents, with its solutions validated through over 880 internal trials and 90+ partner-run studies.[4]
# Origin Story
Provivi was founded in 2013 by Frances Arnold, PhD, who won the Nobel Prize in Chemistry in 2018 for her work on directed evolution—the scientific foundation underlying the company's breakthrough pheromone production technology.[2] Arnold's Nobel Prize-winning research enabled Provivi to solve a critical industry problem: the prohibitively high cost of manufacturing pheromones at scale, which had previously limited their use to specialty crops.[2][4]
The company's early traction came through securing backing from prominent investors. BASF Venture Capital invested in 2017, and the Gates Foundation partnered with Provivi in 2021 through a Series C investment, recognizing the potential of pheromone-based solutions for small-scale producers in low-income geographies.[2][5] These partnerships validated the technology's viability and opened doors to major agricultural corporations seeking sustainable pest management alternatives.
# Core Differentiators
# Role in the Broader Tech Landscape
Provivi operates at the intersection of synthetic biology, sustainable agriculture, and climate adaptation—three converging megatrends reshaping global food systems. As chemical pesticide resistance intensifies and regulatory pressure on synthetic chemicals increases, alternative pest management tools have shifted from niche to essential.[4] The company's pheromone platform exemplifies how Nobel Prize-winning science can be translated into scalable commercial solutions that address both farmer economics and environmental sustainability.
The timing is critical: major agricultural corporations like Syngenta are actively seeking new modes of action to combat insecticide resistance and meet consumer demands for reduced chemical residue.[3] Provivi's partnerships with these giants signal that pheromone-based solutions are transitioning from experimental to mainstream, potentially reshaping integrated pest management practices across millions of acres globally. By making pheromones affordable for commodity crops, Provivi is democratizing a technology previously available only to premium markets, which could influence how the entire agricultural industry approaches pest control.
# Quick Take & Future Outlook
Provivi is positioned to become a foundational technology platform in sustainable agriculture, similar to how Ginkgo Bioworks operates in synthetic biology. The company's flywheel effect—where successful partnerships attract additional corporate collaborators—is just beginning.[4] As registrations expand across more countries and crops, and as climate pressures intensify pest challenges, demand for non-chemical alternatives will likely accelerate.
The key question ahead is whether Provivi can scale manufacturing globally while maintaining cost advantages, and whether pheromone solutions can achieve the market penetration needed to materially reduce synthetic pesticide use. If successful, Provivi could redefine pest management as a biology-first rather than chemistry-first discipline, influencing how billions of dollars in agricultural inputs are allocated over the next decade.
Provivi has raised $152.0M across 3 funding rounds. Most recently, it raised $46.0M Series C in December 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 1, 2020 | $46.0M Series C | Kairos Ventures | |
| Oct 1, 2019 | $85.0M Series C | Kairos Ventures | |
| Nov 1, 2017 | $21.0M Series B | Kairos Ventures |
